Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid.

Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid.

Following oral administration of sulphasalazine, 5-aminosalicylic acid (5-ASA) is present in serum at very low concentrations and is mostly in the acetylated form. Analysis of rectal mucosal biopsies from patients on sulphasalazine maintenance therapy has shown that the predominant metabolite presen...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Ireland, A, Priddle, J, Jewell, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	Informa Healthcare 1988

Documenti analoghi

Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells.
di: Ireland, A, et al.
Pubblicazione: (1990)

Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell.
di: Ireland, A, et al.
Pubblicazione: (1992)

Mechanism of action of 5-aminosalicylic acid and its derivatives.
di: Ireland, A, et al.
Pubblicazione: (1990)

Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid.
di: Chen, D, et al.
Pubblicazione: (1996)

5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon.
di: Paolo, D, et al.
Pubblicazione: (1996)

Sonoelectrochemically enhanced determination of 5-aminosalicylic acid.
di: Beckett, E, et al.
Pubblicazione: (2001)

Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives
di: Wafaa S. Ramadan, et al.
Pubblicazione: (2024-01-01)

Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)
di: Robert D. Crapnell, et al.
Pubblicazione: (2023-12-01)

Human colonic intra-epithelial lymphocytes are suppressor cells.
di: Hoang, P, et al.
Pubblicazione: (1991)

Synthesis and kinetic studies of mutual azo prodrugs of 5-aminosalicylic acid with sulfamethoxazole and trimethoprim as models for colon targeting
di: Yasser Fakri Mustafa
Pubblicazione: (2010-12-01)

Production of epithelial cell growth factors by lamina propria mononuclear cells.
di: Lowes, JR, et al.
Pubblicazione: (1992)

Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
di: M. Campieri, et al.
Pubblicazione: (1989-01-01)

Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid
di: Harshna Patel, et al.
Pubblicazione: (2009-01-01)

Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy
di: Sicheng Tang, et al.
Pubblicazione: (2024-08-01)

Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
di: MG Robinson, et al.
Pubblicazione: (1990-01-01)

Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps
di: Tina Kirchner, et al.
Pubblicazione: (2013-01-01)

Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
di: Hye Young Lee, et al.
Pubblicazione: (2024-05-01)

5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn’s Disease Patients: A Retrospective Study
di: Jian Wan, et al.
Pubblicazione: (2021-01-01)

Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease.
di: Zimmerman, M, et al.
Pubblicazione: (1996)

5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and Proctitis
di: Lloyd R Sutherland, et al.
Pubblicazione: (1987-01-01)

Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy
di: Bharat Kumar Reddy Sanapalli, et al.
Pubblicazione: (2024-08-01)

5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
di: Jihee Kim, et al.
Pubblicazione: (2024-02-01)

Effect of High Dose Aminosalicylic Acid on Gastroduodenal Mucosa
di: DJ Leddin, et al.
Pubblicazione: (1993-01-01)

Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.
di: O'Donnell, L, et al.
Pubblicazione: (1992)

5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.
di: Van Staa, T, et al.
Pubblicazione: (2004)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
di: Cristiana Perrotta, et al.
Pubblicazione: (2015-01-01)

The Protective Effect of 5-Aminosalicylic Acid against Non-Steroidal Anti-Inflammatory Drug-Induced Injury through Free Radical Scavenging in Small Intestinal Epithelial Cells
di: Eun Suk Jung, et al.
Pubblicazione: (2020-10-01)

Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
di: Andrew W Kirkpatrick, et al.
Pubblicazione: (1999-01-01)

Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
di: Hiroshi Matsumoto, et al.
Pubblicazione: (2024-09-01)

Pharmacokinetics of 5-Aminosalicylic Acid Enteral Suspension in Crohn's Disease Patients and Normal Volunteers
di: CN Williams, et al.
Pubblicazione: (1990-01-01)

Prevention of Relapse in Ulcerative Colitis Using Oral or Topical 5-Aminosalicylic Acid Therapy
di: Lloyd R Sutherland
Pubblicazione: (1993-01-01)

Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes.
di: Hoang, P, et al.
Pubblicazione: (1992)

Synthesis and in vitro bioactivity evaluation of new glucose and xylitol ester derivatives of 5- aminosalicylic acid
di: Yousefi, Samira, et al.
Pubblicazione: (2015)

Synthesis and in vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
di: Yousefi, Samira, et al.
Pubblicazione: (2017)

Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
di: M Campieri, et al.
Pubblicazione: (1990-01-01)

New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
di: Kazuhiko Uchiyama, et al.
Pubblicazione: (2014-01-01)

5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats
di: Steven R. Vigna
Pubblicazione: (2014-01-01)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
di: Kazuhiko Uchiyama, et al.
Pubblicazione: (2023-08-01)

Ketotifen Treatment of Active Colitis in Patients with 5-Aminosalicylate Intolerance
di: John K Marshall, et al.
Pubblicazione: (1998-01-01)

Protective Effects of Sodium Para-Aminosalicylic Acid on Lead and Cadmium Co-Exposure in SH-SY5Y Cells
di: Jian-Chao Peng, et al.
Pubblicazione: (2023-02-01)